Disposition of [4-14C]mofebutazone in the rat
- PMID: 7250143
- DOI: 10.1007/BF03189465
Disposition of [4-14C]mofebutazone in the rat
Abstract
The absorption and elimination of radioactivity after the oral or intraperitoneal administration of[4-14C]mofebutazone was studied in rats. The blood concentration of radioactivity reached a maximum after about 0.7 h, fell rapidly until about 2 h, and then declined slowly. There was sometimes a second peak between 3-6 h. Elimination of radioactivity in urine and feces was extensive and rapid. Over a 24 h period, 73% of the orally administered radioactivity was eliminated in the urine and 15% in the faeces; most of this was eliminated during the first 8 h (89% of the urine radioactivity, 56% of the faeces radioactivity). In anaesthetized rats with cannulated bile ducts, 94% of the intraperitoneally injected radioactivity was eliminated in the bile over a 6 h period. Most of the radioactivity (about 85%) eliminated in the bile and the urine was in the form of a glucuronide and only small amounts less than 10%, was in the form of mofebutazone.
Similar articles
-
Pharmacokinetics of [4-14C] mofebutazone after oral administration in man.Eur J Drug Metab Pharmacokinet. 1984 Jul-Sep;9(3):223-7. doi: 10.1007/BF03189645. Eur J Drug Metab Pharmacokinet. 1984. PMID: 6519123
-
[Distribution of 4-14C-mofebutazone in the rat].Z Rheumatol. 1986 Mar-Apr;45(2):83-6. Z Rheumatol. 1986. PMID: 3727816 German.
-
Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs.Arzneimittelforschung. 1998 Oct;48(10):995-1006. Arzneimittelforschung. 1998. PMID: 9825117
-
The disposition of radioactivity after administration of the anthelminthic methyl-14C-5-cyclopropylcarbonyl-2-benzimidazole carbamate (ciclobendazole) to rats and dogs.Arzneimittelforschung. 1977;27(3):593-8. Arzneimittelforschung. 1977. PMID: 577426
-
Absorption, distribution, metabolism and excretion of glucosamine sulfate. A review.Arzneimittelforschung. 2001 Sep;51(9):699-725. doi: 10.1055/s-0031-1300105. Arzneimittelforschung. 2001. PMID: 11642003 Review.
Cited by
-
Pharmacokinetics of [4-14C] mofebutazone after oral administration in man.Eur J Drug Metab Pharmacokinet. 1984 Jul-Sep;9(3):223-7. doi: 10.1007/BF03189645. Eur J Drug Metab Pharmacokinet. 1984. PMID: 6519123